87 related articles for article (PubMed ID: 798199)
1. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
Lageder H; Irsigler K
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
[No Abstract] [Full Text] [Related]
2. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Vessby B; Lithell H; Boberg J; Hellsing K; Werner I
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
[TBL] [Abstract][Full Text] [Related]
3. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
[No Abstract] [Full Text] [Related]
4. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
[No Abstract] [Full Text] [Related]
5. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
Honorato J; Masso RM; Purroy A
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
[No Abstract] [Full Text] [Related]
6. The evaluation of lipoprotein changes during gemfibrozil treatment.
Janus ED; Costa D; Ononogbu IC; Lewis B
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
[TBL] [Abstract][Full Text] [Related]
7. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Olsson AG; Rössner S; Walldius G; Carlson LA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
[TBL] [Abstract][Full Text] [Related]
8. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
9. CI-719 in hyperlipoproteinaemia: interim data.
Bremner WF; Third JL; Clark B; Corstorphine C; Lawrie TD
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201
[No Abstract] [Full Text] [Related]
10. Summary of present data from a clinical trial of CI-719.
Wilkening J; Schwandt P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):90-3. PubMed ID: 1019158
[No Abstract] [Full Text] [Related]
11. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
[TBL] [Abstract][Full Text] [Related]
12. Extrinsic factors affecting the response to gemfibrozil.
Huunan-Seppälä A; Manninen V; Burton R; Eisalo A
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):53-7. PubMed ID: 1019154
[No Abstract] [Full Text] [Related]
13. Gemfibrozil in a group of diabetics.
de Salcedo I; Gorringe AL; Silva JL; Santos JA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
[TBL] [Abstract][Full Text] [Related]
14. Gemfibrozil for hyperlipidemia.
Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
[No Abstract] [Full Text] [Related]
15. Effect of gemfibrozil on serum lipid levels.
Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
Artery; 1980; 7(3):224-31. PubMed ID: 7008748
[TBL] [Abstract][Full Text] [Related]
16. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Rodney G; Uhlendorf P; Maxwell RE
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
[No Abstract] [Full Text] [Related]
17. Hypolipidaemic action of gemfibrozil in adult nephrotics.
Eisalo A; Manninen V; Mälkönen M; Kuhlbäck B
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):47-8. PubMed ID: 798197
[No Abstract] [Full Text] [Related]
18. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
19. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
[No Abstract] [Full Text] [Related]
20. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
Oriente P; Motolese M; Cerqua R; Mancini M
Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
